Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex ...

A one-time subretinal injection of Sura-vec at both high- and low-dose concentrations allowed more than half of patients with ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future ...

ORLANDO ‑- Cataract surgery was linked to an increased risk of conversion from dry to neovascular (wet) age-related macular ...

Despite the recent attention to the potential of developing and using gene therapy to treat several diseases, the therapy was ...

The AMD pipeline presents opportunities via emerging novel therapies focusing on innovative mechanisms such as gene therapy, mitochondria-targeting peptides, and complement inhibition. Key drugs in ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...